NYSE - Delayed Quote USD

Qiagen N.V. (QGEN)

Compare

44.68

-0.58

(-1.28%)

At close: January 10 at 4:00:02 PM EST

44.68

0.00

(0.00%)

After hours: January 10 at 5:05:00 PM EST

QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase

VENLO, Netherlands, January 12, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new plan to return up to approximately $300 million (maximum EUR 281 million) to shareholders through a synthetic share repurchase that combines a direct capital repayment with a reverse stock split.

Business Wire 7 hours ago

QGEN
-1.28%
Qiagen scoops FDA clearance for gastrointestinal panel

QIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in around one hour.

Medical Device Network 2 days ago

QGEN
-1.28%
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples

VENLO, Netherlands, January 10, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analyzed from a single biological sample.

Business Wire 2 days ago

QGEN
-1.28%
QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care

GERMANTOWN, Md., & VENLO, The Netherlands, January 09, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory clearance of the first in a series of QIAstat-Dx Gastrointestinal Panel tests for clinical use.

Business Wire 3 days ago

QGEN
-1.28%
Will Qiagen (QGEN) Beat Estimates Again in Its Next Earnings Report?

Qiagen (QGEN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 3 days ago

QGEN
-1.28%
QGEN Stock Might Rise Following Partnership With Genomics England

QIAGEN partners with Genomics England to support the United Kingdom's initiative to sequence the genomes of 100,000 newborns with expert-curated genomic content.

Zacks 4 days ago

QGEN
-1.28%
RMD
QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content

REDWOOD CITY, Calif. & VENLO, The Netherlands, January 07, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has partnered with Genomics England to support the delivery of the Generation Study.

Business Wire 5 days ago

QGEN
-1.28%
Why Is Qiagen N.V. (QGEN) Among the Top CRISPR Stocks to Invest In?

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Qiagen N.V. (NYSE:QGEN) stands against the other CRISPR stocks. The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge […]

Insider Monkey 13 days ago

QGEN
-1.28%
New Product Offerings Support QIAGEN's Shares Amid Currency Woes

To support internal growth, QIAGEN is investing heavily in R&D for menu expansion of its key platforms.

Zacks 13 days ago

QGEN
-1.28%
Here's Why Qiagen (QGEN) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 13 days ago

QGEN
-1.28%
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 27 days ago

QGEN
-1.28%
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 30 days ago

QGEN
-1.28%
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret

QGEN announces the launch of IPA Interpret to extend the analysis capabilities of a human-curated knowledge base with AI technology.

Zacks 30 days ago

QGEN
-1.28%
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

REDWOOD CITY, Calif. & VENLO, the Netherlands, December 12, 2024--QIAGEN (NYSE: QGEN, Frankfurt Prime Standard: QIA) today announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.

Business Wire last month

QGEN
-1.28%
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?

Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

NVAX

QGEN
-1.28%
QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements

QGEN achieves milestone with more than 1,000 EZ2 Connect placements worldwide, contributing to a global installed base of over 5,500 EZ series instruments.

Zacks last month

QGEN
-1.28%
HAE

RMD
Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound?

Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

QGEN
-1.28%
ALKS
-1.20%
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation

VENLO, Netherlands, December 05, 2024--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has reached a significant milestone with over 1,000 placements of the EZ2 Connect automated sample preparation instrument, an advancement of the EZ1 instrument line.

Business Wire last month

QGEN
-1.28%
Should You Continue to Retain QIAGEN Stock in Your Portfolio Now?

QGEN's robust expansion of its testing menu and potential in molecular diagnostics bode well for investors.

Zacks last month

QGEN
-1.28%
HAE

BSX
Here's Why Qiagen (QGEN) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks last month

QGEN
-1.28%

Performance Overview

Return	QGEN	S&P 500
YTD	-0.07%	-1.35%
1-Year	+2.53%	+22.51%
3-Year	-8.63%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Qiagen N.V. (QGEN)

QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase

Qiagen scoops FDA clearance for gastrointestinal panel

QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples

QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care

Will Qiagen (QGEN) Beat Estimates Again in Its Next Earnings Report?

QGEN Stock Might Rise Following Partnership With Genomics England

QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content

Why Is Qiagen N.V. (QGEN) Among the Top CRISPR Stocks to Invest In?

New Product Offerings Support QIAGEN's Shares Amid Currency Woes

Here's Why Qiagen (QGEN) is a Strong Momentum Stock

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term

QIAGEN Stock Gains Following the Latest Launch of IPA Interpret

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?

QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements

Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound?

QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation

Should You Continue to Retain QIAGEN Stock in Your Portfolio Now?

Here's Why Qiagen (QGEN) is a Strong Value Stock

Performance Overview